Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma
Sign Up to like & getrecommendations! Published in 2024 at "JAMA Oncology"
DOI: 10.1001/jamaoncol.2024.4381
Abstract: Key Points Question Does the addition of lenvatinib to ifosfamide and etoposide (IE) improve treatment outcomes in children and young adults with relapsed or refractory osteosarcoma? Findings In this randomized clinical trial including 81 patients,… read more here.
Keywords: young adults; lenvatinib plus; adults relapsed; plus ifosfamide ... See more keywords